The Cost of Bladder Cancer Care Is Rising. Could Value-Based Care Models Help? The rising cost of care is having a negative impact on patients with bladder cancer, but a value-based approach to care might provide some relief.
ctDNA Testing in Colorectal Cancer Deemed Promising but Not Ready for Prime Time Studies suggest that ctDNA testing has prognostic value in colorectal cancer, but more research is needed before it can be used in practice.
Preventing and Treating COVID-19 in Cancer Patients: Challenges in the Omicron Era Methods to prevent and treat COVID-19 in cancer patients have had to evolve alongside the SARS-CoV-2 virus.
Cardiovascular Risk Stratification for Older Adults Undergoing Cancer Surgery Identifying limitations in functional reserves in the older adult leads to improved decision-making related to cardiovascular risk stratification and elective procedures.
Sexual Health and Cancer: What Providers Need to Know Sexual dysfunction may be common in cancer patients and survivors, but their sexual health is often overlooked.
Patient Portals in Oncology: Helpful or Harmful? Studies and anecdotal reports suggest patient portals can be both beneficial and detrimental for oncology patients and providers.
Cancer Patients May Fall Prey to Illegitimate Online Pharmacies High drug prices and ongoing shortages may prompt cancer patients to buy treatments online and fall prey to illegitimate pharmacies.
Aggregating Data Hides Cancer Disparities Affecting Asian and NHPI Patients in the US Aggregated data can hide disparities in cancer incidence and outcomes among Asian and Native Hawaiian/Pacific Islander patients in the US.
ASH 2022: Promising Results in Newly Diagnosed and Relapsed/Refractory Multiple Myeloma By Carina Storrs, PhD
AML Research From ASH 2022: Novel Combinations and Evidence That “Less is More” By Tori Rodriguez, MA, LPC, AHC